Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

December 31, 2009

Conditions
Solid Tumour
Interventions
DRUG

PHA-848125AC

Trial Locations (2)

21212

The Johns Hopkins University, Baltiomore

85258

Scottsdale Clinical Research Institute, Scottsdale

Sponsors
All Listed Sponsors
lead

Nerviano Medical Sciences

INDUSTRY

NCT01300468 - Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter